Abstract:Gene manipulation using Cre-loxP recombination has proven to be an important approach for studying the impact of gene expression on pancreatic β-cell biology. We report the generation of a transgenic mouse line that enables a highly specific system for conditional gene manipulation within β-cells and achieve tissue specific and temporally regulated deletion of the Ctnnb1 (β-catenin) gene in pancreatic β-cells. cDNA encoding Cre recombinase fused to modified estrogen receptor (CreERT) under control of mouse insulin 1 gene promoter (Ins1) was used to construct the mouse line Tg(Ins1-Cre/ERT)1Lphi, also termed MIP1-CreERT. In a cross of MIP1-CreERT with a ROSA26/LacZ reporter strain, tamoxifen [Tmx] - dependent β-galactosidase expression occurred within pancreatic β-cells but not in other organ systems. Intraperitoneal glucose tolerance tests and glucose-stimulated changes in β-cell cytoplasmic calcium concentration were not adversely affected in adult MIP1-CreERT. A mouse line with floxed Ctnnb1 gene (Ctnnb1f/f) was crossed with the MIP1-CreERT line to generate a mouse model for inducible β-cell specific deletion of β-catenin gene (Ctnnb1f/f:MIP1-CreERT). Ctnnb1f/f:MIP1-CreERT mice and Ctnnb1f/f littermate controls, were injected with Tmx as adults to knock down β-catenin production in the majority of pancreatic β-cells. These mice showed normal glucose tolerance, islet cyto-architecture and insulin secretion. A novel protein fraction of 50Kd, immunoreactive with anti-β-catenin was observed in islet extracts from Ctnnb1f/f:MIP1-CreERT[Tmx] mice but not MIP1-CreERT-negative Ctnnb1f/f[Tmx] controls, indicating possible presence of a cryptic protein product of recombined Ctnnb1 gene. The MIP1-CreERT mouse line is a powerful tool for conditional manipulation of gene expression in β-cells.

The Construction of a Cre Recombinase Expression Vector That Targets the Expression of Cre in Pancreas of Transgenic Mouse

Construction and Tissue Specific Expression of Cre Transgenic Mice

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

Generation and Characterization of Transgenic Mice Expressing Mouse Ins1 Promoter for Pancreatic Β-Cell-specific Gene Overexpression and Knockout.

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

Construction of Mouse Gene-targeting Vector Through Modified Recombineering Strategy

Cre Reconstitution Allows for Dna Recombination Selectively in Dual-Marker-Expressing Cells in Transgenic Mice

Gene splicing of Cre and Construction of Transgenic Cell

Generation of CRISPR/Cas9-mediated bicistronic knock-in ins1-cre driver mice

Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells

1855-PUB: Generation and Identification of Pik3r3 Gene Pancreatic Beta-Cell Knockout Mice Model

Construction of Transgenic Swine with Induced Expression of Cre Recombinase

Construction of Inducible Cre Recombinase Expression Transgenic Porcine Fibroblast Line

Stable Transgenic Mouse Strain with Enhanced Photoactivatable Cre Recombinase for Spatiotemporal Genome Manipulation

Construction of a Mouse Novel Gene Targeting Vector and Recombination Screening

Generation and Characterization of Transgenic Mice Expressing Tamoxifen-Inducible Cre-Fusion Protein Specifically in Mouse Liver.

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

Conditional Gene Modification in Mouse Liver Using Hydrodynamic Delivery of Plasmid Dna Encoding Cre Recombinase

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation

Strategies and Applications of the Cre/Loxp System in Transgenic Mice.

Construction of Afp-cre-lacZ Transgenic Mouse Model